Physician profile
Jasmine Kashkoush
NPI 1538728126
$2,705.81
in general payments reported to CMS, 2019-2025
18 companies · $806 in 2025
The $806 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $124 · 2021: $34.59 · 2022: $367 · 2023: $179 · 2024: $1,195 · 2025: $806.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,488 · Travel and Lodging: $651 · Education: $40.86.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,488.36 |
| Travel and Lodging | $651.42 |
| Education | $40.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,364.68 | 2021-2025 | Bulkamid, Axonics, Solyx Sis System |
| Axonics, INC. | $452.19 | 2022-2024 | Bulkamid, Axonics |
| Urogen Pharma, INC. | $202.79 | 2025 | |
| Olympus America INC. | $135.83 | 2025 | Hd Camera Head |
| Kci USA, INC. | $123.53 | 2019 | |
| Sumitomo Pharma America, INC. | $57.32 | 2025 | Gemtesa |
| Ambu INC. | $51.20 | 2022 | |
| Abc Home Medical Supply, INC. | $50.97 | 2025 | |
| Astellas Pharma US INC | $42.83 | 2023 | |
| Medtronic, INC. | $40.86 | 2024 | Signia |
| Ferring Pharmaceuticals INC. | $35.83 | 2024-2025 | Adstiladrin |
| Tempus Ai, INC | $29.82 | 2025 | Xt Cdx |
| Antares Pharma, INC. | $24.26 | 2025 | Xyosted |
| Karl Storz Endoscopy-America | $20.31 | 2023 | |
| Verity Pharmaceuticals INC. | $18.96 | 2025 | Tlando |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $18.32 | 2025 | Deknatel |
| Abbvie INC. | $18.17 | 2025 | |
| Coopersurgical, INC. | $17.94 | 2025 | Ally II Ups |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jasmine Kashkoush listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.